<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39457527</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>The Spectrum of Adrenal Lesions in a Tertiary Referral Center.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2214</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12102214</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adrenal tumors are a common finding in clinical practice, and only detailed evaluation may reveal secretory and metabolic abnormalities or their malignant character. We aimed to highlight epidemiological data, rates of malignancy, clinical or secretory characteristics, and the cardiometabolic implications of adrenal masses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective analysis using data from the medical files of 474 patients with adrenal pathology hospitalized between January 2007 and January 2020, before the COVID-19 pandemic, using the ICD-10 codes. After applying inclusion and exclusion criteria, a total of 264 patients with adrenal tumors were enrolled in the study. Patients underwent clinical examination, abdominal imaging, and hormonal evaluation, and some of them underwent a pathological exam after adrenalectomy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median age at diagnosis was 56 (17) years, with 81.06% of patients being female. The median follow-up period was 41.5 (70) months, ranging from 6 months to 13 years. Adrenal tumors were most frequently seen in older female patients, with 83.47% of them being over 40 years old. The malignancy rate was 4.54%. Hormonally nonfunctioning tumors (71.95%) predominated, and overt hypercortisolism was present in 10.61% of patients, as was mild autonomous cortisol secretion in 5.31% of patients, primary hyperaldosteronism in 8.71% of patients, and adrenal paraganglioma in 3.41% of patients. Cardiometabolic comorbid conditions were similar in patients with functioning and nonfunctioning tumors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">All patients with adrenal tumors should receive a complete hormonal workup and detailed malignancy risk assessment. Even though a hormonally active tumor predisposes to cardiometabolic comorbid conditions, a nonfunctioning lesion may also be associated with such disorders and needs thorough assessment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Carmen Sorina</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0001-9622-8883</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrei</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voicu</LastName><ForeName>Bianca Alina</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riță</LastName><ForeName>Miruna Alexandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Department, Bucharest Emergency University Hospital, 050098 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taralunga</LastName><ForeName>Ana Alice</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, 'Dr. Carol Davila' Central Military Emergency University Hospital, 010242 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sîrbu</LastName><ForeName>Anca Elena</ForeName><Initials>AE</Initials><Identifier Source="ORCID">0000-0003-3659-4544</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cima</LastName><ForeName>Luminita Nicoleta</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoian</LastName><ForeName>Iulia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbu</LastName><ForeName>Carmen Gabriela</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-2678-7318</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calu</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miron</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9609-8775</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fica</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenal cancer</Keyword><Keyword MajorTopicYN="N">adrenal incidentaloma</Keyword><Keyword MajorTopicYN="N">adrenal paraganglioma</Keyword><Keyword MajorTopicYN="N">adrenal tumor</Keyword><Keyword MajorTopicYN="N">autonomous cortisol secretion</Keyword><Keyword MajorTopicYN="N">primary hyperaldosteronism</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457527</ArticleId><ArticleId IdType="pmc">PMC11504223</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12102214</ArticleId><ArticleId IdType="pii">biomedicines12102214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherlock M., Scarsbrook A., Abbas A., Fraser S., Limumpornpetch P., Dineen R., Stewart P.M. Adrenal Incidentaloma. Endocr. Rev. 2020;41:775–820. doi: 10.1210/endrev/bnaa008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnaa008</ArticleId><ArticleId IdType="pmc">PMC7431180</ArticleId><ArticleId IdType="pubmed">32266384</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Bindman R., Miglioretti D.L., Johnson E., Lee C., Feigelson H.S., Flynn M., Greenlee R.T., Kruger R.L., Hornbrook M.C., Roblin D., et al. Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996–2010. JAMA. 2012;307:2400–2409. doi: 10.1001/jama.2012.5960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5960</ArticleId><ArticleId IdType="pmc">PMC3859870</ArticleId><ArticleId IdType="pubmed">22692172</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassnacht M., Arlt W., Bancos I., Dralle H., Newell-Price J., Sahdev A., Tabarin A., Terzolo M., Tsagarakis S., Dekkers O.M. Management of Adrenal Incidentalomas: European Society of Endocrinology Clinical Practice Guideline in Collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2016;175:G1–G34. doi: 10.1530/EJE-16-0467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-16-0467</ArticleId><ArticleId IdType="pubmed">27390021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassnacht M., Tsagarakis S., Terzolo M., Tabarin A., Sahdev A., Newell-Price J., Pelsma I., Marina L., Lorenz K., Bancos I., et al. European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenal Incidentalomas, in Collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2023;189:G1–G42. doi: 10.1093/ejendo/lvad066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejendo/lvad066</ArticleId><ArticleId IdType="pubmed">37318239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Alì A.A., Giovagnetti M., Opocher G., Angeli A. A Survey on Adrenal Incidentaloma in Italy. J. Clin. Endocrinol. Metab. 2000;85:637–644. doi: 10.1210/jc.85.2.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.85.2.637</ArticleId><ArticleId IdType="pubmed">10690869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasperlik-Załuska A.A., Otto M., Cichocki A., Rosłonowska E., Słowińska-Srzednicka J., Jeske W., Papierska L., Zgliczyński W. Incidentally Discovered Adrenal Tumors: A Lesson from Observation of 1444 Patients. Horm. Metab. Res. 2008;40:338–341. doi: 10.1055/s-2008-1073167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1073167</ArticleId><ArticleId IdType="pubmed">18491253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargav P.R.K., Mishra A., Agarwal G., Agarwal A., Verma A.K., Mishra S.K. Adrenal Incidentalomas: Experience in a Developing Country. World J. Surg. 2008;32:1802–1808. doi: 10.1007/s00268-008-9550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-008-9550-8</ArticleId><ArticleId IdType="pubmed">18425548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin X., Qing Y., Linhui W., Li G., Yinghao S. Adrenal Incidentalomas: Experience from a Retrospective Study in a Chinese Population. Urol. Oncol. 2011;29:270–274. doi: 10.1016/j.urolonc.2009.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2009.03.027</ArticleId><ArticleId IdType="pubmed">19481963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S.H., Kim J.H., Baek S.H., Kim H., Cho Y.Y., Suh S., Kim B.J., Hong S., Koh J.M., Lee S.H., et al. Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea. Yonsei Med. J. 2018;59:501–510. doi: 10.3349/ymj.2018.59.4.501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2018.59.4.501</ArticleId><ArticleId IdType="pmc">PMC5949292</ArticleId><ArticleId IdType="pubmed">29749133</ArticleId></ArticleIdList></Reference><Reference><Citation>Corssmit E.P.M., Dekkers O.M. Screening in Adrenal Tumors. Curr. Opin. Oncol. 2019;31:243–246. doi: 10.1097/CCO.0000000000000528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000000528</ArticleId><ArticleId IdType="pubmed">30844886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbehoj A., Li D., Kaur R.J., Zhang C., Singh S., Li T., Atkinson E., Achenbach S., Khosla S., Arlt W., et al. Epidemiology of Adrenal Tumours in Olmsted County, Minnesota, USA: A Population-Based Cohort Study. Lancet Diabetes Endocrinol. 2020;8:894–902. doi: 10.1016/S2213-8587(20)30314-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30314-4</ArticleId><ArticleId IdType="pmc">PMC7601441</ArticleId><ArticleId IdType="pubmed">33065059</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkuş G., Evran M., Sert M., Ok F., Tetiker T. Multidisciplinary Approach for Patients with Functional and Non-Functional Adrenal Masses and Review of the Literature. Health Sci. Rep. 2017;1:e22. doi: 10.1002/hsr2.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.22</ArticleId><ArticleId IdType="pmc">PMC6266456</ArticleId><ArticleId IdType="pubmed">30623061</ArticleId></ArticleIdList></Reference><Reference><Citation>Comlekci A., Yener S., Ertilav S., Secil M., Akinci B., Demir T., Kebapcilar L., Bayraktar F., Yesil S., Eraslan S. Adrenal Incidentaloma, Clinical, Metabolic, Follow-up Aspects: Single Centre Experience. Endocrine. 2010;37:40–46. doi: 10.1007/s12020-009-9260-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-009-9260-5</ArticleId><ArticleId IdType="pubmed">19882253</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruda M., Mello Ribeiro Cavalari E., Pessoa De Paula M., Fernandes Cordeiro De Morais F., Furtado Bilro G., Alves Coelho M.C., De Oliveira E Silva De Morais N.A., Choeri D., Moraes A., Vieira Neto L. The Presence of Nonfunctioning Adrenal Incidentalomas Increases Arterial Hypertension Frequency and Severity, and Is Associated with Cortisol Levels after Dexamethasone Suppression Test. J. Hum. Hypertens. 2017;32:3–11. doi: 10.1038/s41371-017-0011-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-017-0011-4</ArticleId><ArticleId IdType="pubmed">29176595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Kim M.J., Lee J.H., Yoon J.W., Shin C.S. Nonfunctioning Adrenal Incidentalomas Are Not Clinically Silent: A Longitudinal Cohort Study. Endocr. Pract. 2020;26:1406–1415. doi: 10.4158/EP-2020-0182.</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP-2020-0182</ArticleId><ArticleId IdType="pubmed">33471732</ArticleId></ArticleIdList></Reference><Reference><Citation>Can B., Karaca Özer P., Can B., Telci Çaklili Ö. Assessment of Subclinical Cardiovascular Alterations in Nonfunctioning Adrenal Incidentalomas. Turk. J. Med. Sci. 2022;52:677–682. doi: 10.55730/1300-0144.5360.</Citation><ArticleIdList><ArticleId IdType="doi">10.55730/1300-0144.5360</ArticleId><ArticleId IdType="pmc">PMC10390162</ArticleId><ArticleId IdType="pubmed">36326332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yumuk V., Tsigos C., Fried M., Schindler K., Busetto L., Micic D., Toplak H. European Guidelines for Obesity Management in Adults. Obes. Facts. 2015;8:402–424. doi: 10.1159/000442721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000442721</ArticleId><ArticleId IdType="pmc">PMC5644856</ArticleId><ArticleId IdType="pubmed">26641646</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee. ElSayed N.A., Aleppo G., Bannuru R.R., Bruemmer D., Collins B.S., Ekhlaspour L., Gaglia J.L., Hilliard M.E., Johnson E.L., et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S20–S42. doi: 10.2337/DC24-S002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/DC24-S002</ArticleId><ArticleId IdType="pmc">PMC10725812</ArticleId><ArticleId IdType="pubmed">38078589</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably E.A.E., et al. 2023 ESH Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J. Hypertens. 2023;41:1874–2071. doi: 10.1097/HJH.0000000000003480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000003480</ArticleId><ArticleId IdType="pubmed">37345492</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Classification of Tumours Online.  [(accessed on 11 January 2024)].  Available online:  https://tumourclassification.iarc.who.int/welcome/</Citation></Reference><Reference><Citation>Davenport C., Liew A., Doherty B., Win H.H.N., Misran H., Hanna S., Kealy D., Al-Nooh F., Agha A., Thompson C.J., et al. The Prevalence of Adrenal Incidentaloma in Routine Clinical Practice. Endocrine. 2011;40:80–83. doi: 10.1007/s12020-011-9445-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-011-9445-6</ArticleId><ArticleId IdType="pubmed">21547511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovio S., Cataldi A., Reimondo G., Sperone P., Novello S., Berruti A., Borasio P., Fava C., Dogliotti L., Scagliotti G.V., et al. Prevalence of Adrenal Incidentaloma in a Contemporary Computerized Tomography Series. J. Endocrinol. Investig. 2006;29:298–302. doi: 10.1007/BF03344099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03344099</ArticleId><ArticleId IdType="pubmed">16699294</ArticleId></ArticleIdList></Reference><Reference><Citation>de Magalhães L.J.T., Rocha V.G., de Almeida T.C., Albuquerque E.V.d.A. Prevalence of Reported Incidental Adrenal Findings in Chest Computerized Tomography Scans Performed during the COVID-19 Pandemic in a Single Center in Northeast Brazil. Arch. Endocrinol. Metab. 2023;67:251. doi: 10.20945/2359-3997000000592.</Citation><ArticleIdList><ArticleId IdType="doi">10.20945/2359-3997000000592</ArticleId><ArticleId IdType="pmc">PMC10689037</ArticleId><ArticleId IdType="pubmed">36913677</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppa M., Koliaki C., Raptis S.A. Adrenal Incidentalomas and Cardiometabolic Morbidity: An Emerging Association with Serious Clinical Implications. J. Intern. Med. 2010;268:555–566. doi: 10.1111/j.1365-2796.2010.02291.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2010.02291.x</ArticleId><ArticleId IdType="pubmed">20964741</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyranska-Chyrek E., Szczepanek-Parulska E., Olejarz M., Ruchala M. Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center. Int. J. Environ. Res. Public Health. 2019;16:1872. doi: 10.3390/ijerph16101872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16101872</ArticleId><ArticleId IdType="pmc">PMC6571894</ArticleId><ArticleId IdType="pubmed">31137898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichijo T., Ueshiba H., Nawata H., Yanase T. A Nationwide Survey of Adrenal Incidentalomas in Japan: The First Report of Clinical and Epidemiological Features. Endocr. J. 2020;67:141–152. doi: 10.1507/endocrj.EJ18-0486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ18-0486</ArticleId><ArticleId IdType="pubmed">31694993</ArticleId></ArticleIdList></Reference><Reference><Citation>Öz B., Akcan A., Emek E., Akyüz M., Sözüer E., Akyıldız H., Bayram A., Kulu R., Ok E. Laparoscopic Surgery in Functional and Nonfunctional Adrenal Tumors: A Single-Center Experience. Asian J. Surg. 2016;39:137–143. doi: 10.1016/j.asjsur.2015.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asjsur.2015.04.009</ArticleId><ArticleId IdType="pubmed">26170103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro Cavalari E.M., de Paula M.P., Arruda M., Carraro N., Martins A., de Souza K., Coelho M.C., de Oliveira e Silva de Morais N.A., Moraes A.B., Vieira Neto L. Nonfunctioning Adrenal Incidentaloma: A Novel Predictive Factor for Metabolic Syndrome. Clin. Endocrinol. 2018;89:586–595. doi: 10.1111/cen.13822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.13822</ArticleId><ArticleId IdType="pubmed">30044007</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>